Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schaaf

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
The Lancet. Infectious Diseases|October 2, 2025
Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosisJames A Seddon, Jay Achar, Amyn A Malik, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Plos Medicine|July 12, 2018
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysisElizabeth P Harausz, Anthony J Garcia-Prats, Stephanie Law, et al.
Pathogens (Basel, Switzerland)|February 26, 2022
Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income CountriesKaren du Preez, Betina Mendez Alcântara Gabardo, Sushil K Kabra, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Plos Medicine|September 7, 2012
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsShama D Ahuja, David Ashkin, Monika Avendano, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
The Lancet. Infectious Diseases|October 2, 2025
Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosisJames A Seddon, Jay Achar, Amyn A Malik, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Plos Medicine|July 12, 2018
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysisElizabeth P Harausz, Anthony J Garcia-Prats, Stephanie Law, et al.
Pathogens (Basel, Switzerland)|February 26, 2022
Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income CountriesKaren du Preez, Betina Mendez Alcântara Gabardo, Sushil K Kabra, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Plos Medicine|September 7, 2012
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsShama D Ahuja, David Ashkin, Monika Avendano, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 18